BOLD fundamentals
An in-depth look to Boundless Bio, Inc. operating, investing, and financing activities
BOLD free cash flow for Q3 24 is -13.75 M USD. For 2023, BOLD free cash flow was -47.49 M USD and operating cash flow was -46.85 M USD.
Q3 '22
Q4 '22
Q1 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM